Preventive role of carvedilol in adriamycin-induced cardiomyopathy

Preventive role of carvedilol in adriamycin-induced cardiomyopathy

Background & objectives: Adriamycin though considered as an effective anticancer drug, leads to irreversible cardiomyopathy (CMP) and congestive heart failure (CHF). The aim of this study was to determine the protective effect of carvedilol in adriamycin (ADR)-induced cardiomyopathy (CMP) in can...

Full description

Bibliographic Details
Main Authors: Rajesh Jhorawat, Savita Kumari, Subhash C Varma, Manoj K Rohit, Nidhi Narula, Vikas Suri, Pankaj Malhotra, Sanjay Jain
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2016-01-01
Series:Indian Journal of Medical Research
Subjects:
Adriamycin - cardiomyopathy - carvedilol - chemotherapy - ejection fraction - fraction shortening
Online Access:http://www.ijmr.org.in/article.asp?issn=0971-5916;year=2016;volume=144;issue=5;spage=725;epage=729;aulast=Jhorawat

Internet

http://www.ijmr.org.in/article.asp?issn=0971-5916;year=2016;volume=144;issue=5;spage=725;epage=729;aulast=Jhorawat

Similar Items